In vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells

scientific article

In vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1359-4117.2003.01069.X
P698PubMed publication ID12822512

P2093author name stringSubhash C Gautam
Xiaohua Gao
Dorrah Deeb
Nalini Janakiraman
Robert A Chapman
Yong X Xu
P2860cites workMaturation, activation, and protection of dendritic cells induced by double-stranded RNAQ36367830
TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivoQ36375923
High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodesQ36380488
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activityQ40785578
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
TNF-alpha gene therapy with myeloid progenitor cells lacks the toxicities of systemic TNF-alpha therapy.Q40940218
Antileukemic activity of TNF-alpha gene therapy with myeloid progenitor cells against minimal leukemiaQ41041020
The role of cytokines in functional regulation and differentiation of dendritic cellsQ41228239
Dendritic cell development and maturation.Q41586693
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cellsQ57275942
Enhanced Dendritic Cell Maturation by TNF- or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In VivoQ63408466
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunityQ71563753
Dendritic cells and the control of immunityQ27860918
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaQ28251443
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorQ29619247
TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infectionQ33947075
Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivoQ36262520
Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cellsQ36354420
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitroQ36363984
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1Q36364968
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunityQ36366051
P433issue2
P921main subjectgene therapyQ213901
P304page(s)62-71
P577publication date2003-03-01
P1433published inJournal of Experimental Therapeutics & OncologyQ27714289
P1476titleIn vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells
P478volume3

Search more.